grant

Global Cancer Health

Organization DIVISION OF CANCER EPIDEMIOLOGY AND GENETICSLocation UNITED STATES
NIHUS FederalResearch GrantFY2025AIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAdult femalesAdult womenAfrica South of the SaharaAnalAnogenital cancerAnti-HIV PositivityAntibodiesAnusAssayBioassayBiological AssayBloodBlood Reticuloendothelial SystemBreast LumpBreast NoduleCancer ControlCancer Control ScienceCancer InterventionCancersCausalityCervical CancerCervix CancerCountryDevelopmentDoseEffectivenessEnrollmentEtiologyEvaluationFemale GroupsFemales in adulthoodFocus GroupsFutureGardasilGenotypeGoalsHIVHIV PositiveHIV PositivityHIV SeroconversionHIV SeronegativitiesHIV SeronegativityHIV SeropositivityHIV antibody positiveHIV negativeHPV VaccinationHPV detection testsHPV diagnostic testHPV testHPV testsHTLV-III SeroconversionHTLV-III SeronegativitiesHTLV-III SeronegativityHTLV-III SeropositivityHealthHigh Risk WomanHistoryHumanHuman Immunodeficiency VirusesHuman Papilloma Virus VaccinationHuman Papillomavirus VaccinationImmuneImmunesImmunityImmunization ProgramsLAV-HTLV-IIILMICLymphadenopathy-Associated VirusMalignant Cervical NeoplasmMalignant Cervical TumorMalignant Neoplasm of the CervixMalignant NeoplasmsMalignant Oral Cavity NeoplasmMalignant Oral Cavity TumorMalignant Oral NeoplasmMalignant TumorMalignant Tumor of the CervixMalignant Tumor of the Cervix UteriMalignant Uterine Cervix NeoplasmMalignant Uterine Cervix TumorMalignant neoplasm of cervix uteriMass in breastModern ManMouth CancerNatural HistoryObservation researchObservation studyObservational StudyObservational researchOralOral CancerPalpableParticipantPopulationPredicting RiskPrevalencePreventionQuestionnairesR-Series Research ProjectsR01 MechanismR01 ProgramRecording of previous eventsResearchResearch GrantsResearch Project GrantsResearch ProjectsResearch SpecimenRisk FactorsRuandaRwandaSexual HealthSpecimenSub-Saharan AfricaSubsaharan AfricaTestingUnderserved PopulationUpper aerodigestive tract cancerUterine Cervix CancerVaccinatedVaccinationVaccination ProgramsVaccinesValidationVirusVirus-HIVWomanWomen in adulthoodWomen's GroupWomen's studyat-risk femalesat-risk womenbreast masscausationcervicovaginalcohortdevelopmentaldisease causationenrollfemale studyfemales at high riskforecasting riskhigh risk femaleshistorieshuman papillomavirus detection testshuman papillomavirus diagnostic testhuman papillomavirus testhuman papillomavirus testslow and middle-income countriesmalignancymalignant mouth neoplasmmalignant mouth tumorneoplasm/cancernew approachesnew technologynon vaccinatednot vaccinatednovel approachesnovel strategiesnovel strategynovel technologiesoral cavity cancerpalpable diseasepredict riskpredict riskspredicted riskpredicted riskspredicting riskspredictive riskpredicts riskpreventpreventingprogramsprophylacticrisk predictionrisk predictionsscreeningscreeningsstudy among femalesstudy among womenstudy in femalesstudy in womenstudy on femalesstudy on womenstudy within womensymptom scienceunder served groupunder served individualunder served peopleunder served populationunderserved groupunderserved individualunderserved peopleunvaccinatedvaginal biomevaginal microbiomevalidationswomen at high risk
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

My research program and group are focused on discovery, development, and evaluation/validation of new technologies for the prevention and control of cancer in underserved populations globally. Our current objectives are 1) to optimize screening and prophylactic HPV vaccination to prevent anogenital cancers, especially in those living with HIV, 2)…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Global Cancer Health — DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS | UNITED STATES | Dev Procure